Full-Time

Provider Relations Manager

Posted on 9/17/2025

Synapticure

Synapticure

51-200 employees

24/7 telehealth neurology for neurodegenerative care

No salary listed

Albuquerque, NM, USA

In Person

Field-based position requiring regular in-person practice visits.

Category
Sales & Account Management (1)
Requirements
  • 5+ years of experience in field sales, provider engagement, or practice relations within healthcare or health technology
  • Proven ability to engage primary care providers and clinical leadership using a consultative approach
  • Strong communication and presentation skills, comfortable with clinical and administrative stakeholders
  • Highly organized, self-motivated, and able to manage a geographically dispersed portfolio and multiple priorities
  • Understanding of primary care environments, workflows, and challenges strongly preferred
  • Ability to work independently in the field while collaborating effectively with internal teams
  • Familiarity with neurodegenerative diseases or population health programs a plus
Responsibilities
  • Build and maintain strong relationships with primary care providers, practice managers, and delivery system leadership in the local market
  • Serve as Synapticure’s in-field representative, communicating the mission, program benefits, and value proposition to clinical teams
  • Use consultative engagement techniques to overcome objections and address practice needs with empathy and problem-solving
  • Collaborate with internal teams to coordinate practice onboarding, training, and support during and after program rollout
  • Achieve and exceed monthly practice engagement and adoption targets, tracking activity and reporting progress to leadership
  • Facilitate in-practice education sessions and provide resources to help practices integrate Synapticure programs into workflows
  • Identify practice-specific challenges and collaborate with cross-functional teams to implement tailored solutions
  • Provide feedback from the field to inform program improvements and enhance both provider and patient experiences
  • Schedule recurring practice visits to maintain referral pipelines and support engagement with hard-to-reach patients
  • Deliver professional presentations and product demonstrations tailored to clinical and administrative audiences
  • Document engagement activities, challenges, and outcomes in CRM/tracking tools and provide timely reporting on key insights, risks, and progress
Desired Qualifications
  • Understanding of primary care environments, workflows, and challenges strongly preferred
  • Familiarity with neurodegenerative diseases or population health programs a plus

Synapticure provides 24/7 telehealth for people with neurodegenerative diseases, delivering virtual neurology and behavioral health care to patients and caregivers from home. How it works: patients book and receive care from neurologists, behavioral health providers, and care coordinators via telehealth, with integrated behavioral health services and up-to-date science guidance to help understand options and access new treatments or clinical trials. Revenue comes from fees for telehealth sessions, paid by patients, insurers, or both. How it stands out: a specialized focus on ALS, Alzheimer’s, Huntington’s, and Parkinson’s, plus care coordination and behavioral health integration, backed by founders with personal ALS experience and doctors who are described as empathetic and knowledgeable. Goal: improve access to expert neurodegenerative care, support patients and caregivers, and connect them with treatments and clinical trials through a science-informed virtual platform.

Company Size

51-200

Company Stage

Series A

Total Funding

$31.1M

Headquarters

Chicago, Illinois

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • $25M Series A funding in 2023 fuels nationwide expansion and partnerships.
  • Joe Leinbach’s COO hire from Cityblock scales value-based payer contracts.
  • Michael J. Fox Foundation advisory accelerates Parkinson’s trial enrollment.

What critics are saying

  • Teladoc’s Teleneuro captures payer contracts, eroding Synapticure’s share by Q4 2026.
  • Amazon One Medical undercuts pricing with AI monitoring via Prime access in 2026.
  • UnitedHealth Optum launches identical model using Synapticure data by June 2026.

What makes Synapticure unique

  • Synapticure specializes in nationwide virtual neurology for ALS, Alzheimer’s, Parkinson’s, Huntington’s.
  • Co-founders Brian Wallach and Sandra Abrevaya bring personal ALS experience to empathetic care.
  • 95 NPS score reflects exceptional patient satisfaction from specialized, proactive support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Remote Work Options

Home Office Stipend

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

-3%
Modern Healthcare
Nov 21st, 2024
Top digital health funding: Morgan Health backs autism startup

In April 2023, Cortica received $75 million in a Series D funding round led by Optum Ventures.

FinSMEs
Nov 20th, 2024
Synapticure Raises $25M Series A

Synapticure, a Chicago, IL-based virtual care company dedicated to improving access and outcomes for patients and caregivers living with Alzheimer's and related dementias, Parkinson's, and other neurodegenerative diseases, raised $25M in Series A funding

Endpoints News
Nov 15th, 2024
SynaptiCure Raises $25M for Virtual Care

SynaptiCure has raised $25 million for its virtual approach to neurodegenerative disease care.

BioSpace
Oct 5th, 2023
National Institutes Of Health Awards $45.1 Million Ninds Grant For Cnm-Au8® Study In Alsfunding To Support Research And Expanded Access Of Investigational Drug In Als

SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH), to support an Expanded Access Protocol (EAP) for the Company’s investigational drug, CNM-Au8®, in amyotrophic lateral sclerosis (ALS). An EAP is also referred to as Compassionate Use and is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S. Food and Drug Administration (FDA)

Yahoo Finance
Sep 6th, 2023
Synapticure Welcomes Joe Leinbach As Chief Operating Officer And Expands Coverage To Additional Neurological Conditions

As the first nationwide virtual clinic specializing in neurodegenerative disease, Synapticure scales leadership team to meet the rapidly growing needs of patients, payers and providersCHICAGO, Sept. 6, 2023 /PRNewswire/ -- Synapticure , a virtual clinic transforming treatment and outcomes for individuals and their caregivers living with neurodegenerative diseases, announced Joe Leinbach has joined as the company's first Chief Operating Officer. Leinbach joins at a critical time for the company's expansion into additional neurodegenerative conditions including Alzheimer's and related Dementias, while creating new ways to expand patient access through innovative partnerships with health systems and health plans.A veteran of early stage value-based care innovators, Leinbach has driven growth and operational success in leadership roles at Cityblock Health and Evolent Health. His background includes scaling operations to serve individuals with complex physical and behavioral health needs, and structuring partnerships with payers and providers to improve patient costs and outcomes. Joe will lead the company's next phase of growth and efforts to implement innovative models that directly benefit patients and partners.Founded in 2021 by Brian Wallach and Sandra Abrevaya, the co-founders of I AM ALS , Synapticure's care teams now provide services to all 50 states + DC, providing specialized neurology care, integrated behavioral health, and care coordination to help patients and their caregivers navigate the complexities of neurodegenerative diseases. Through proactive, patient-centered support, Synapticure's patients have enrolled in clinical trials they otherwise wouldn't have accessed, were prescribed new medications and supplements changing their quality of life, avoided costly hospitalizations and ER visits, and received support for issues with medical equipment, insurance benefits and other care needs.Story continues"We've proven that patients and caregivers love working with Synapticure's specialized neurologists, as shown by our incredible NPS (Net Promoter Score) of 95

INACTIVE